BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

520 related articles for article (PubMed ID: 28737646)

  • 1. CRP/Albumin Ratio: An Early Predictor of Steroid Responsiveness in Acute Severe Ulcerative Colitis.
    Gibson DJ; Hartery K; Doherty J; Nolan J; Keegan D; Byrne K; Martin ST; Buckley M; Sheridan J; Horgan G; Mulcahy HE; Cullen G; Doherty GA
    J Clin Gastroenterol; 2018 Jul; 52(6):e48-e52. PubMed ID: 28737646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploration of Predictive Biomarkers of Early Infliximab Response in Acute Severe Colitis: A Prospective Pilot Study.
    Beswick L; Rosella O; Rosella G; Headon B; Sparrow MP; Gibson PR; van Langenberg DR
    J Crohns Colitis; 2018 Feb; 12(3):289-297. PubMed ID: 29121178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoalbuminemia and Bandemia Predict Failure of Infliximab Rescue Therapy in Acute Severe Ulcerative Colitis.
    Syal G; Robbins L; Kashani A; Bonthala N; Feldman E; Fleshner P; Vasiliauskas E; McGovern D; Ha C; Targan S; Melmed GY
    Dig Dis Sci; 2021 Jan; 66(1):199-205. PubMed ID: 32170473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective validation of AIIMS index as a predictor of steroid failure in patients with acute severe ulcerative colitis.
    Sahu P; Jain S; Kedia S; Vuyyuru SK; Sahni P; Sharma R; Panwar R; Das P; Gupta V; Makharia G; Travis S; Ahuja V
    Indian J Gastroenterol; 2022 Jun; 41(3):273-283. PubMed ID: 35474175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting response after infliximab salvage in acute severe ulcerative colitis.
    Choy MC; Seah D; Gorelik A; An YK; Chen CY; Macrae FA; Sparrow MP; Connell WR; Moore GT; Radford-Smith G; Van Langenberg DR; De Cruz P
    J Gastroenterol Hepatol; 2018 Jul; 33(7):1347-1352. PubMed ID: 29266456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved outcome of acute severe ulcerative colitis while using early predictors of corticosteroid failure and rescue therapies.
    Llaó J; Naves JE; Ruiz-Cerulla A; Gordillo J; Mañosa M; Maisterra S; Cabré E; Garcia-Planella E; Guardiola J; Domènech E
    Dig Liver Dis; 2016 Jun; 48(6):608-12. PubMed ID: 27012443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-reactive protein level at 2 weeks following initiation of infliximab induction therapy predicts outcomes in patients with ulcerative colitis: a 3 year follow-up study.
    Iwasa R; Yamada A; Sono K; Furukawa R; Takeuchi K; Suzuki Y
    BMC Gastroenterol; 2015 Aug; 15():103. PubMed ID: 26271624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infliximab as a rescue therapy for hospitalized patients with severe ulcerative colitis refractory to systemic corticosteroids.
    Yamamoto-Furusho JK; Uzcanga LF
    Dig Surg; 2008; 25(5):383-6. PubMed ID: 19005257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-Dose Infliximab Rescue Therapy for Hospitalized Acute Severe Ulcerative Colitis Does Not Improve Colectomy-Free Survival.
    Chao CY; Al Khoury A; Aruljothy A; Restellini S; Wyse J; Afif W; Bitton A; Lakatos PL; Bessissow T
    Dig Dis Sci; 2019 Feb; 64(2):518-523. PubMed ID: 30446928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Managing paediatric acute severe ulcerative colitis according to the 2011 ECCO-ESPGHAN guidelines: Efficacy of infliximab as a rescue therapy.
    Aloi M; D'Arcangelo G; Capponi M; Nuti F; Vassallo F; Civitelli F; Oliva S; Pagliaro G; Cucchiara S
    Dig Liver Dis; 2015 Jun; 47(6):455-9. PubMed ID: 25733340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early predictors of colectomy and long-term maintenance of remission in ulcerative colitis patients treated using anti-tumour necrosis factor therapy.
    Subramaniam K; Richardson A; Dodd J; Platten J; Shadbolt B; Pavli P
    Intern Med J; 2014 May; 44(5):464-70. PubMed ID: 24612209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corticosteroid exposure prior to admission and predicting need for rescue therapy in acute severe ulcerative colitis.
    Barnes A; Spizzo P; Mountifield R
    Intern Med J; 2022 May; 52(5):828-833. PubMed ID: 33197107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of infliximab as rescue therapy for ulcerative colitis refractory to tacrolimus.
    Yamamoto S; Nakase H; Matsuura M; Honzawa Y; Masuda S; Inui K; Chiba T
    J Gastroenterol Hepatol; 2010 May; 25(5):886-91. PubMed ID: 20546441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcomes of infliximab treatment and predictors of response in 195 patients with ulcerative colitis: a hospital-based cohort study from Korea.
    Seo H; Chang K; Lee SH; Song EM; Kim GU; Seo M; Lee HS; Hwang SW; Yang DH; Kim KJ; Ye BD; Byeon JS; Myung SJ; Yang SK; Park SH
    Scand J Gastroenterol; 2017 Aug; 52(8):857-863. PubMed ID: 28502189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inpatient infliximab is ineffective at preventing colectomy for steroid refractory extensive colitis.
    Andrew RE; Lauria A; Puleo FJ; Berg A; Stewart DB
    J Surg Res; 2017 Nov; 219():18-24. PubMed ID: 29078879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ability of different rescue therapies to save the bowel in acute, severe, steroid-refractory ulcerative colitis.
    Farkas K; Molnár T; Szepes Z
    Expert Rev Gastroenterol Hepatol; 2014 Aug; 8(6):695-702. PubMed ID: 24738535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early Response to Corticosteroid and Baseline C-Reactive Protein Predicts Outcomes in Children with Moderate to Severe Ulcerative Colitis.
    Deva Rajoo G; Tan L; Lopez A; Lewindon P; Grover Z
    Dig Dis Sci; 2019 Jul; 64(7):1929-1937. PubMed ID: 30734233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-Term Efficacy and Safety of Cyclosporine in a Cohort of Steroid-Refractory Acute Severe Ulcerative Colitis Patients from the ENEIDA Registry (1989-2013): A Nationwide Multicenter Study.
    Ordás I; Domènech E; Mañosa M; García-Sánchez V; Iglesias-Flores E; Peñalva M; Cañas-Ventura A; Merino O; Fernández-Bañares F; Gomollón F; Vera M; Gutiérrez A; Garcia-Planella E; Chaparro M; Aguas M; Gento E; Muñoz F; Aguirresarobe M; Muñoz C; Fernández L; Calvet X; Jiménez CE; Montoro MA; Mir A; De Castro ML; García-Sepulcre MF; Bermejo F; Panés J; Esteve M
    Am J Gastroenterol; 2017 Nov; 112(11):1709-1718. PubMed ID: 28675163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term combination therapy with infliximab plus azathioprine predicts sustained steroid-free clinical benefit in steroid-dependent ulcerative colitis.
    Armuzzi A; Pugliese D; Danese S; Rizzo G; Felice C; Marzo M; Andrisani G; Fiorino G; Nardone OM; De Vitis I; Papa A; Rapaccini GL; Guidi L
    Inflamm Bowel Dis; 2014 Aug; 20(8):1368-74. PubMed ID: 24983979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarker dynamics during infliximab salvage for acute severe ulcerative colitis: C-reactive protein (CRP)-lymphocyte ratio and CRP-albumin ratio are useful in predicting colectomy.
    Con D; Andrew B; Nicolaides S; van Langenberg DR; Vasudevan A
    Intest Res; 2022 Jan; 20(1):101-113. PubMed ID: 33902267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.